Skip to main content
Springer Nature - PMC COVID-19 Collection logoLink to Springer Nature - PMC COVID-19 Collection
. 2018 Sep 25:1021–1028. doi: 10.1007/978-3-319-99921-0_80

Dangerous Microbes

Bjørg Marit Andersen 2,3,
PMCID: PMC7122166

Abstract

The most dangerous microbes for humans are those that are easily transmitted, virulent and invasive to central organs like the blood and lung, robust survivors in the environment, have a low infection dose and are without any specific treatment or vaccine. Most of them are zoonoses transmitted from animals and often with insects as vectors. The most dangerous microbes cause a very high mortality, are identified as high-risk agents or “biohazard-level 4” agents and are treated at the highest level of infection protection with strict isolation measures. Dangerous microbes occur as a problem mostly in countries with low hygiene standards/high population density and in tropical-subtropical areas. Infection control must always be based on hygienic measures and strict infection protection.

This chapter is a short information about the most virulent and pathogenic agents, geographic area and severity of disease.

Keywords: Microbes, Dangerous microbes, Geographic area of virulent agents, Dangerous virus and bacteria, Zoonosis, VHF, Anthrax, Plague, Biosafety level 4, Infection control, Survivors, High-risk microbes, Severity of disease

Dangerous Microbes

New, emerging or re-emerging infectious diseases and agents still appear. More than 15 new potential human pathogenic microbe types may be registered every year. New infectious diseases and emerging virulence properties still appear, for example, avian influenza viruses (H5N1 and others), HTLV and other retroviruses, HPV, Sindbis virus, Parvovirus, Bocavirus, Coronavirus, or bacteria like Legionella, Borrelia, group A streptococci and meningococci [15].

Virus not vaccine preventable or without specific treatment option, low infection dose and high capacity to survive in the environment will be a major problem if associated with incurable disease, disability or death. Virulent and dangerous microbes occur as a problem mostly in countries with low hygiene standards/high population density and in tropical-subtropical areas. Infection control must be based on hygienic measures and proper infection protection [27].

The most dangerous microbes for humans are those that are easily transmitted, virulent and invasive to the central organs like the blood and lung, robust survivors in the environment, have a low infection dose and are without any specific treatment or vaccine [25]. Most of them are zoonosis transmitted from animals and often with insects as vectors [812]. Dangerous microbes have also been used as biological weapons like anthrax, plague, botulism, Coxiella, Brucella, viral haemorrhagic fever (VHF) viruses, poxviruses and a number of other unusual agents [4, 1325]. In the United States, there was an anthrax bioterrorism attack in 2001 [18, 19].

If the infectious agent and transmission ways are unknown and the situation is uncontrollable, it is important to follow pre-planned practical measures like strict isolation in negative air pressure isolation, registering of all contacts and the use of personal protective equipment (PPE) for air- and contact-borne infection [4, 813, 17, 20, 24, 2629].

Dangerous Virus

During the last 20 years, there have been several large outbreaks of new and re-emerging viruses. Examples are systemic acute respiratory syndrome (SARS) (2002–2003), avian influenza viruses (H5N1, 2005), pandemic influenza (2009), Middle East respiratory syndrome (MERS) (2012) and Ebola (2014 and 2016) [1, 4, 5, 8, 11, 12].

VHF virus and a number of other special viruses are considered to cause the world’s most dangerous infections with very high mortality, lack of therapeutic possibilities and often absence of effective vaccines. Such viruses are identified as high-risk agents or “biohazard-level 4” agents and are treated at the highest level of infection protection with strict isolation measures [4, 11, 12, 2628].

  • Virus families, with members especially dangerous to humans, are Arenaviridae, Filoviridae, Flaviviridae, Bunyaviridae, Togaviridae and Paramyxoviridae (Nipah encephalitis virus, etc.) and several others. They are mostly vector borne by insects and animals (zoonosis), dependent on a tropical-subtropical climate and temperature. Therefore, the colder zones in Europe, America, Asia and Australia are nearly free from more such serious infectious agents (see the table below) [1, 2, 4, 11, 12].

  • Some very virulent viruses may be spread on all continents: TBE, RSSE, CCHF, rabies virus (Rhabdoviridae), avian influenza virus (AH5N1) and other high-pathogenic influenza viruses (Orthomyxoviridae). SARS and MERS (Coronaviridae) may be spread globally as nosocomial infections. MERS is a newly discovered coronavirus-zoonosis (dromedaries, bats, etc.) and acts as SARS, also with a tendency for nosocomial spread in hospitals, still going on in the Middle East. [30] These and other viruses are adapted to the climate and spread by direct transmission person-to-person, by increased mobility in the population and/or spread via new vectors, like animals, birds and insects [1, 4].

  • A few of these dangerous viruses are vaccine preventable, and specific antiviral therapy is lacking in most cases.

Other New Virulent Viruses

  • Zika virus—newly discovered flavivirus in South America, with mild to serious symptoms and teratogenic effect [11].

  • Polio-like illnesses, especially among children, discovered in August 2014 in the United States. Probably caused by enterovirus D68 [31].

  • HIV aggressive variants (CRF19) have been detected in Cuba in 2015 and earlier in Africa, with a faster course from infection to AIDS development [32].

Dangerous Bacteria

Bacteria resistant to antibacterial drugs have developed rapidly among staphylococci (MRSA), enterococci (VRE), tuberculosis bacilli (multidrug-resistant mycobacteria) and gram-negative rods (ESBL) in the last 30–50 years. From 2009 to 2010 onwards, super-resistant gram-negative rods (CRE, CPE) have increased rapidly with transmission of genes with total drug resistance (NDM-1) [15]. Bacteria sensitive to common antibacterial agents will probably not be a major problem in the future, unless changed antibacterial sensitivity.

  • Anthrax is still endemic or hyperendemic on all continents in the world, mainly as a zoonosis among unvaccinated cattle [16, 13, 33]. It has been known for more than 4000 years and was earlier called “Black bane”. Natural anthrax in human is associated with contact with sick animals and animal products. The bacterium Bacillus anthracis is producing lethal toxins and spores that can survive in the environments for 100 years or more. Minimum infectious dose is 1–3 spores, and toxin-producing anthrax may cause skin, lung or intestinal anthrax, dependent on the transmission via contact, air or food. The non-skin anthrax has a very high lethality. Today, about 2000 people are infected each year, from eating or handling infected meat. During peace time, there are few incidents of threats using bioterror weapons like anthrax. However, autumn 2001 anthrax was spread in the United States by “powder letters” [18, 19].

  • Plague, caused by Yersinia pestis (Enterobacteriaceae), is a zoonotic disease, vector-transmitted from infected rodents to humans via infected insects (fleas and lice) [15, 8]. It is one of the great historical diseases. In the last 1500 years, plague has killed more than 200 million people during large epidemics (Black Death), especially from the year 1347. Still, plague causes bubonic-glandular pest, lung pest and/or septicaemia in 2000–3000 cases each year, and more than 10 outbreaks (Africa, Asia, Australia, Madagascar) have occurred since the year 2000 [8, 34].

  • Cholera caused by Vibrio cholera is one of the great quarantine diseases, called “mother of all epidemics”, still very active in Asia and Africa. Cholera is associated with contaminated water, war and nature catastrophes, like in Haiti 2010, with 670,000 cholera cases (profuse diarrhoea) [15, 35].

  • Brucella species (Brucellaceae) are one of the most important zoonotic diseases both for animals and humans all over the world. They easily spread via contact and air from animals and food, survive in the environment for months especially during colder seasons, are very easily transmitted and may cause nosocomial infections, chronic febris undulans, septicaemia and lung diseases. Vaccination of animals may eradicate the zoonotic disease [15]. Brucella are particularly related to laboratory outbreaks but are easily transferable outside the laboratory and are considered highly infectious [36].

  • Francisella tularensis (zoonosis) is defined as a category A bioterrorism agent, highly infectious and increasing in the society, has low infection dose (one to ten bacteria) and can be inhaled or infected via food and water [15, 8]. Occasionally, such patients are detected in hospitals, even in the operating department [37]. Tularemia is a zoonotic disease or colonization among wild animals as rodents and hares and may survive at colder seasons for long periods in water, amoebas, birds and insects like ticks. The infection (skin, lung, intestine) is transmitted via contact with infected animals, inhalation of airborne bacteria, contaminated water and ticks.

  • Botulism is caused by a bacterial-produced toxin (Clostridium botulinum) that causes paresis and is common in soil as spores [15]. The disease can be associated with toxin formation in contaminated and poorly canned foods, shrimp fish, bacon, etc. under anaerobic conditions and randomly affects both healthy people and vulnerable groups, such as infants who have had honey infected with the bacterium, which has happened repeatedly [38]. The toxin is the most dangerous we know and is on the list of bioterrorism.

  • Family Rickettsiaceae is associated with many different types of small, intracellular microbes that are zoonotic and survive for a long time in the nature and in infected animals, birds, insects, water and amoeba [2, 3, 10]. Coxiella burnetii is a global zoonosis among animals like sheep and goats and may be airborne for several kilometres, causing frequent outbreaks of Q-fever in Europe in more than 4000 cases in the Netherlands during 2007–2010 [10]. Rickettsia species are more than 25 types, and many of them, especially the typhus group, are causing severe diseases. Humans are mostly infected by insects, including ticks from infected wild animals and rodents usually found in tropical or subtropical areas, but climatic changes, lack of good hygiene, war and natural catastrophes may spread these infections. During the period 1881–1920, 30 million people got epidemic typhus, and three million died in East Europe and Russia [2, 3, 10].

Other Bacteria That Are Causing Concern

  • Borrelia (Spirochetaceae) has an increasing number of species that may infect human cases all over the world. The disease may cause chronic infections in the skin, muscles, heart, nerve tissue and brain. Borreliosis is a typical emerging zoonosis, spread via different ticks from animals and birds over large geographic areas and with large climatic variations [9].

  • Syphilis (Spirochetaceae) and Treponema pallidum are old, historical diseases, transmitted via sex, from mother to child during pregnancy and via blood products. Now re-emerging and increasing worldwide [9].

  • Other spirochetes or the like may cause zoonosis, like Borrelia recurrentis and Leptospirosis [9].

  • Burkholderia pseudomallei is causing melioidosis, pneumonia, septicaemia, disseminated infection and shock. Incubation period may be up to 20–40 years. It is a long survivor in the environment (2–10 years), robust at tropical-subtropical temperatures >25 °C and is very dangerous. Endemic in Southeast Asia and may be spread by increasing globalization [15].

Other Infective/Dangerous Agents

  • Fungi and mould—different types are especially related to floods, water damage, etc. and to contamination of medical products and equipment [39, 40]. Especially, the newly defined Candida auris may be very virulent.

  • Prion disease-new Shy-Drager syndrome is rediscovered in 2015; Multiple-system atrophy (MSA) [5, 41].

  • Ricin is a plant-derived toxin that is still used for bioterrorism in letters to, among others, President Obama [42].

Serious and unusual microbial infections

Microbes Geographic area Disease
Virus
Arena virus
Lassa West Africa Severe, often fatal
Guanarito Venezuela Severe
Junin (Argentine haemorrhagic fever-HF) Argentina Severe
Machupo (Bolivian haemorrhagic fever) Bolivia Severe
Sabia Brazil Severe
LCM Global Mild to severe
Filovirus
Marburg Africa 23–100 % fatal
Ebola Africa 20–100 % fatal
Bunyaviridae (over 60 viral types from asymptomatic to fatal)
Rift Valley fever Africa 1 % develops HF
California enceph United States, Europe 2 % fatal
Crimean-Congo haemorrhagic fever (CCHF) Africa, Asia, Europe Severe
Hantaan group North and South America, Europe, Asia Moderate to severe
Arbovirus (Togaviridae and Flaviviridae)
Tick​-borne (TBE) encephalitis virus complex All continents Moderate to fatal
Russian spring and summer encephalitis (RSSE)
Omsk haemorrhagic fever
Central European encephalitis viruses
Venezuelan equine encephalitis virus Moderate to severe
Yellow fever virus Africa, America Moderate to severe
Semliki Forest virus Africa, epidemic Mild to fatal
Dengue virus All tropical-subtropical areas Mild to fatal
Japanese B encephalitis Asia; Korea, Japan, Philippines Often fatal
Rabies In all parts of the world 100% fatal without tr.
Monkey pox (B) Animal experiments Severe, often fatal
Smallpox Virus Eradicate, but kept Severe, often fatal in unvaccinated
Avian influenza A H5N1 Asia, Africa, Europe 80% fatal without treat
Nipah encephalitis virus (paramyxovirus) Asia, Malaysia, India, Bangladesh 75% fatal
Corona Virus
 Systemic acute respiratory syndrome (SARS) Asia, Canada, proliferation Severe, 10% fatal
 Middle East respiratory syndrome (MERS) Middle East, emerging Severe, 30–40% fatal
Bacteria
Richettsiaceae
Rickettsia All continents Many types, severe
Orientia Asia, Australia Moderate to severe
Bartonellaceae All continents Moderate to severe
Coxiella burnetii All continents Moderate to severe
Bacillus anthracis All continents Moderate to severe
Brucella All continents Mild to severe
Burkholderia pseudomallei Asia Mild to severe
Francisella tularensis All continents Mild to severe
Vibrio cholera Asia, Africa and South America Mild to severe
Bacillus anthracis All continents Moderate to severe
Yersinia pestis Africa and Asia Moderate to severe

Footnotes

Current agents are described in more detail in: Andersen BM. Part 1. Microbiology and infection protection. Fagbokforlaget 2014.

References

  • 1.Mandell D. Bennet’s principles and practice of infectious diseases. 8. Philadelphia: Churchill Livingston; 2015. [Google Scholar]
  • 2.Andersen BM. Pathogenic bacteria-diagnostic, treatment and infection control. Oslo: Gyldendal Akademisk; 2000. [Google Scholar]
  • 3.Andersen BM. Bacteria and disease. Oslo: Gyldendal Academisk; 2005. [Google Scholar]
  • 4.Andersen BM, Lereim I, Hochlin K. Handbook in hygiene and infection control for hospitals. Oslo: Ullevål University Hospital; 2008. Serious, unusual dangerous infections; pp. 550–591. [Google Scholar]
  • 5.Andersen BM. Handbook in hygiene and infection control for hospitals. Part 1. Microbiology and infection control. Norway: Fagbokforlaget; 2014. [Google Scholar]
  • 6.European Parliament and Council Directive 2000/54/EC of 18 September 2000 on the protection of workers from the risks related to exposure to biological agents at work.
  • 7.Ministry of Labour and Administration. Regulations on protection against exposure to biological factors (bacteria, viruses, fungi and more) in the workplace. FOR OSLO: 1997-12-19 nr.1322.
  • 8.Andersen BM. Handbook in hygiene and infection control for hospitals. Part 1. Norway: Fagbokforlaget; 2014. Zoonosis-transmitted from animals, insects and environment; pp. 144–153. [Google Scholar]
  • 9.Andersen BM. Handbook in hygiene and infection control for hospitals. Part 1. Norway: Fagbokforlaget; 2014. Borreliosis and other spirochetes-zoonosis; pp. 154–162. [Google Scholar]
  • 10.Andersen BM. Handbook in hygiene and infection control for hospitals. Part 1. Norway: Fagbokforlaget; 2014. Coxiella, rickettsia and other small bacteria – often intracellular – zoonosis; pp. 163–166. [Google Scholar]
  • 11.Andersen BM. Handbook in hygiene and infection control for hospitals. Part 1. Norway: Fagbokforlaget; 2014. Other serious viral infections - zoonosis; pp. 278–290. [Google Scholar]
  • 12.Andersen BM. Handbook in hygiene and infection control for hospitals. Part 1. Norway: Fagbokforlaget; 2014. Ebola, Lassa, and other haemorrhagic viruses; pp. 291–299. [Google Scholar]
  • 13.Andersen BM. Anthrax and emergency routines at Ullevål University Hospital. Tidsskr Nor Legeforen. 2002;122:852–855. [PubMed] [Google Scholar]
  • 14.Borio L, Inglesby BL, Peters CJ, et al. Haemorrhagic fever viruses as biological weapons: medical and public health management. JAMA. 2002;287:2391–2405. doi: 10.1001/jama.287.18.2391. [DOI] [PubMed] [Google Scholar]
  • 15.Jernigan JA, Stephens DS, Ashford DA, Omenaca C, Topiel MS, Galbraith M, et al. Bioterrorism-related inhalation anthrax: the first 10 cases reported in the United States. Emerg Infect Dis. 2001;7:933–944. doi: 10.3201/eid0706.010604. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Inglesby TV, O’Toole T, Hendersen DA, et al. Anthrax as a biological weapon, 2002: updated recommendations for management. JAMA. 2002;287:2236–2252. doi: 10.1001/jama.287.17.2236. [DOI] [PubMed] [Google Scholar]
  • 17.Yakupogullari Y, Koroglu M. Nosocomial spread of Bacillus anthracis. J Hosp Infect. 2007;66:401–440. doi: 10.1016/j.jhin.2007.05.002. [DOI] [PubMed] [Google Scholar]
  • 18.Dull PM, Wilson KE, Kournikakis B, Whitney EAS, Boulet CA, Ho JYW, et al. Bacillus anthracis aerosolization associated with a contaminated mail sorting machine. Emerg Infect Dis. 2002;8:1044–1047. doi: 10.3201/eid0810.020356. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Weis CP, Intrepido AJ, Miller AK, Cowin PG, Durno MA, Gebhart JS, et al. Secondary aerosolization of viable Bacillus anthracis spores in a contaminated US Senate office. J Am Med Ass. 2002;288:2853–2858. doi: 10.1001/jama.288.22.2853. [DOI] [PubMed] [Google Scholar]
  • 20.Peters CJ, Hartley DM. Anthrax inhalation and lethal human infection. Lancet. 2002;359:710–711. doi: 10.1016/S0140-6736(02)07792-9. [DOI] [PubMed] [Google Scholar]
  • 21.Byrne D. Bioterrorism: crime and opportunity. Eurosurveillance. 2001;6:157–158. doi: 10.2807/esm.06.11.00382-en. [DOI] [PubMed] [Google Scholar]
  • 22.Coignard B. Bioterrorism preparedness and response in European public health institutes. Eurosurveillance. 2001;6:159–166. doi: 10.2807/esm.06.11.00383-en. [DOI] [PubMed] [Google Scholar]
  • 23.Levy-Bruhl D, Guerin N. The use of smallpox virus as a biological weapon: the vaccination situation in France. Eurosurveillance. 2001;6:171–178. doi: 10.2807/esm.06.11.00385-en. [DOI] [PubMed] [Google Scholar]
  • 24.Rebman T. APIC text of infection control and epidemiology. St. Louis: APIC, St. Louis University; 2014. Infectious disease disaster: bioterrorism, emerging infections, and pandemics; pp. 1201–1222. [Google Scholar]
  • 25.English JF, Cundiff MY, Malone JD et al. Bioterrorism readiness plan: a template for healthcare facilities. APIC, CDC; 13 April 1999.
  • 26.Promed mail September 14, 2014. Andersen BM. Infection control is not working.
  • 27.Andersen BM. International infection control guidelines for Ebola. Hospital Healthcare Europe. Facilities management; April 2015. www.hospitalhealthcare.com.
  • 28.CDC. Guidance on personal protective equipment to be used by Healthcare Workers during management of patients with Ebola virus disease in US hospitals, including procedures for putting on (donning) and removal, 20 October 2014.
  • 29.McKay I, Sax H, Harbarth S, Bernard L, Pittet D. Multi-resistant infections in repatriated patients after natural disaster: lessons learned from the 2004 tsunami for hospital infection control. J Hosp Infect. 2008;68:1–8. doi: 10.1016/j.jhin.2007.10.018. [DOI] [PubMed] [Google Scholar]
  • 30.Promed-mail August 28, 2015. MERS-COV: Jordan, Saudi Arabia, Nosocomial.
  • 31.Pastula DM, Aliabadi N, Haynes AK, et al. Acute neurological disease of unknown etiology in children - Colorado, August-September 2014. MMWR. 2014;63:1–2. [PMC free article] [PubMed] [Google Scholar]
  • 32.Promed-mail February 14, 2015. HIV-Cuba: New aggressive variant, CRF19.
  • 33.Andersen BM. Anthrax. Bacteria and disease. Epidemiology, infections and infection protection. Oslo: Gyldendal Akademisk; 2005. pp. 9–44. [Google Scholar]
  • 34.Promed mail November 21, 2014. Plague - Madagascar.
  • 35.Andersen BM. Handbook in hygiene and infection control for hospitals. Part 1. Norway: Fagbokforlaget; 2014. Cholera (Vibrio cholerae) pp. 105–107. [Google Scholar]
  • 36.Lowe CF, Showler AJ, Perera S, et al. Hospital-associated transmission of Brucella melitensis outside the laboratory. Emerg Infect Dis. 2015;21:150–152. doi: 10.3201/eid2101.141247. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Becker SL, Splettesteesser WD, Kim YJ, et al. Potential risk of aerosol-borne Francisella tularensis transmission in the operating room. Infect Control Hosp Epidemiol. 2015;36:490–491. doi: 10.1017/ice.2015.4. [DOI] [PubMed] [Google Scholar]
  • 38.Valley ML, Bye K, Nilsen KB, Rørvik LM, Tessem GAG. An infant with acute paresis. Tidsskr Nor Legeforen. 2015;135:1455–1458. doi: 10.4045/tidsskr.14.1419. [DOI] [PubMed] [Google Scholar]
  • 39.CDC. Brandt M, Brown C, Burkhart J, et al. Mould-preventing strategies and possible health effects in the aftermath of hurricanes and major floods. MMWR. 2006;55:1–27. [PubMed]
  • 40.Andersen BM. Handbook in hygiene and infection control for hospitals. Part 1. Norway: Fagbokforlaget; 2014. Fungi-human pathogenic; pp. 393–399. [Google Scholar]
  • 41.Promed-mail September 17, 2015. Prion disease updated: novel prion disease - SHY-DRAGER syndrome.
  • 42.Promed-mail April 17, 2013. Ricin-USA: Washington, DC, Letters.

Articles from Prevention and Control of Infections in Hospitals are provided here courtesy of Nature Publishing Group

RESOURCES